Anaconda BioMed

medical devices

About

Anaconda Biomed S.L. is a medical device company based in Barcelona, founded in 2015 by experts in neurology and biomedical engineering, Dr. Marc Ribó and Dr. Ofir Arad. The company focuses on developing advanced thrombectomy systems to improve the treatment of ischemic stroke, a major cause of disability and death globally. Their mission is to enhance the quality of life for patients and their families by providing healthcare professionals with effective thrombectomy solutions. The flagship product, the ANA Funnel Catheter, is part of the Advanced Neurovascular Access (ANA) system. This innovative device is designed to restore blood flow in patients experiencing acute ischemic stroke due to large vessel occlusions. Anaconda Biomed is actively engaged in clinical validation and regulatory approval processes for its products, including the ANA5 device, and is preparing for CE Mark certification and FDA submission to enter European and U.S. markets. The company has secured over €39 million in funding to support its clinical trials and production scale-up efforts.

Technologies

ElasticEmail Gmail Google Apps Microsoft Office 365

Keywords

health medical devices stroke thrombectomy medical equipment manufacturing suction force biotechnology local flow restriction ana 5 neurovascular devices innovation flow restriction technology stroke device regulatory process stroke intervention in vitro studies safety and efficacy funnel catheter interventional neurology human clinical studies next-generation thrombectomy swine clot model medical device innovation clinical validation in vivo studies european patent for thrombectomy device medical equipment and supplies manufacturing stroke disability reduction medical device preclinical studies stroke clinical trials

Location

56 Carrer d'Eivissa, Sant Quirze del Valles, Catalonia, Spain, 08192

Related Companies

Companies in the same industry